Keyphrases
3D Bioprinting
16%
Acute Respiratory Distress Syndrome
29%
Adult Cardiomyocytes
10%
Angiogenesis
17%
Angiogenic Potential
16%
Antiangiogenic Activity
17%
Antibiotics
16%
Antimicrobial Activity
24%
Antimicrobial Peptides
24%
Antimicrobial Proteins
13%
At Birth
16%
Attenuation
16%
B Cells
16%
Bioink
16%
Cardiomyocytes
21%
Cardiopathy
16%
Cecal Ligation
12%
Cecal Puncture
12%
Cell Current
16%
Cell Subsets
16%
Cell-based
21%
Chorion
16%
Clinical Grade
16%
Clinical Investigation
10%
Combination Therapy
16%
COVID-19
16%
Cryopreserved
16%
Cutaneous Regeneration
16%
Cyclooxygenase-2
10%
Differentiation Potential
16%
Drug Discovery
16%
Endometrial Stem Cells
57%
Endothelial Cells
13%
Exosomes
35%
Gelatin Methacryloyl (GelMA)
16%
Genetic Polymorphism
16%
Haploidentical
16%
Hematopoietic Stem Cells
16%
High-level Expression
8%
High-resolution
16%
Human Mesenchymal Stem Cells (hMSCs)
18%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
17%
Immunological Barrier
16%
Immunosuppressive Potential
17%
Infiltration Process
10%
Inflammatory Cell Infiltration
16%
Inflammatory Cells
10%
Inflammatory Genes
16%
Inflammatory Response
9%
Intercommunication
16%
Intravenous Infusion
16%
Lipopolysaccharide
16%
Lung Injury
10%
Lupus
16%
Matrix Metalloproteinases
16%
Matrix Signals
16%
Menstrual Blood
20%
Mesenchymal Stem Cell Therapy
16%
Mesenchymal Stem Cells
75%
Mesenchymal Stromal Cells
32%
MicroRNA
19%
MicroRNA Profiling
16%
Multi-material
16%
Neonatal Rat Cardiomyocytes
10%
NF-B
16%
Nitric Oxide
16%
Nitric Oxide Synthase 2
27%
Novel Biomarkers
16%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
16%
Organ Dysfunction
10%
Patients with Heart Failure
16%
Peptide-based Therapeutics
16%
Placental Cells
16%
Printed Structures
8%
Prostaglandins
10%
Psychrophiles
16%
Pulmonary Arterial Hypertension
16%
Randomized Clinical Trial
16%
Randomized Controlled Trial
16%
Rat Cardiomyocytes
16%
Respiratory Infection
16%
Respiratory Viruses
16%
Risk Factors
16%
Secreted Factors
16%
Sepsis
35%
Septic Shock
8%
Septicemia
10%
Signaling Pathway
10%
Stem Cell Exosomes
16%
Stem Cell Support
16%
Stem Cell Therapy
16%
Survival Rate
8%
Systemic Lupus Erythematosus
25%
Systemic Lupus Erythematosus Patient
16%
Technical Barriers
16%
Therapeutic Avenues
16%
Therapeutic Effect
10%
Tumor Growth
16%
Tumor Necrosis Factor-α
16%
Wound Matrix
16%
Immunology and Microbiology
Angiogenesis
19%
Animal Cell
5%
Antimicrobial Activity
21%
Antimicrobial Agent
32%
Antimicrobial Peptides
27%
B Cell
9%
Bacterial Clearance
7%
Bacterial Growth
5%
Biological Functions
10%
Bone Marrow Derived Mesenchymal Stem Cell
16%
C57BL 6 Mouse
5%
Cardiac Muscle Cell
16%
Chorion
16%
Collagen Fiber
5%
Colony Forming Unit S
9%
Colony-Forming Unit
6%
Cryopreservation
5%
Drug Megadose
5%
Elastic Fiber
5%
Endogenous Retrovirus
5%
Escherichia coli
5%
Exosome
22%
Extracellular Matrix
5%
Fibroblast
7%
Genetic Polymorphism
16%
Hematopoietic Cell
16%
Herpesviridae
5%
Immunosuppressive Drug
16%
Inflammation Response
10%
Inflammatory Cell
16%
Inflammatory Cytokine
10%
Lineages
6%
Liquid
6%
Low Drug Dose
5%
Lung Mechanics
5%
Lupus Erythematosus
16%
Lymphocyte Subpopulation
5%
Major Histocompatibility Complex
5%
Mediator
16%
Memory B Cell
6%
Mesenchymal Stem Cell
100%
Mesenchymal Stem Cell Transplantation
13%
Morbidity
5%
Mortality Rate
5%
Mouse Model
10%
Naive B Cell
6%
Nitric Oxide Synthase 2
16%
Optimal Drug Dose
5%
Peritoneal Fluid
5%
Prostaglandin
10%
Pulmonary Artery
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Secretion (Process)
13%
Squamous Cell
16%
Stem Cell
33%
Stem Cell Transplantation
18%
Survival Rate
10%
Systemic Inflammation
5%
Systemic Lupus Erythematosus
31%
Tumor Necrosis Factor Alpha
16%
Vasculotropin
6%
Medicine and Dentistry
Acute Respiratory Distress Syndrome
10%
Angiogenesis
16%
Antimicrobial Agent
16%
Biological Marker
16%
Cardiac Muscle Cell
16%
Cell Therapy
19%
Chorion
16%
Clinical Study
5%
Congestive Heart Failure
16%
Coronavirinae
5%
COVID-19
16%
Cyclooxygenase 2
6%
Cytokine
6%
Drug Therapy
5%
Ejection Fraction
9%
Endothelial Cell
6%
Exosome
22%
Heart Disease
16%
Hematopoietic Cell
16%
Immunosuppressive Drug
16%
Inducible Nitric Oxide Synthase
6%
Influenza A Virus (H5N1)
5%
Influenza A Virus (H9N2)
5%
Influenza Virus
5%
Intravenous Drug Administration
16%
Lipopolysaccharide
6%
Lupus Erythematosus
16%
Mediator
5%
Mesenchymal Stem Cell
51%
Mesenchymal Stem Cell Transplantation
13%
microRNA
19%
Mouth Squamous Cell Carcinoma
16%
Patient Population
5%
Pulmonary Hypertension
16%
Randomized Clinical Trial
16%
Randomized Controlled Trial
16%
Respiratory Tract Infection
5%
Signal Transduction
6%
Stem Cell
17%
Stem Cell Therapy
16%
Stromal Cell
16%
Systemic Lupus Erythematosus
29%
Tumor Progression
16%
Umbilical Cord
17%
Umbilical Cord-Derived Mesenchymal Stem Cell
13%
Virus Infection
16%